Medical Research Finder

Start
Features
Free trial / FAQ

Researchers
Physicians
Pharmacists
Ecotrophologists
Product Managers
in Health Industries

Loading…

© 2026 meRfi®

Medical Research Finder

Legal Notice
Privacy
Terms of Use

meRfi® Microbiome - The Digital Gut Microbiome Reference (incl. AI Chat)

AuthorsReferences (Sources)

AuthorsReferences (Sources)

meRfi® AI Chat

Cephalosporins & Clostridioides (Clostridium) difficile

Navigation

Contents

Cephalosporins, particularly third-generation cephalosporins, are major risk factors for Clostridioides difficile infection (CDI)
Szymczak et al. 2020 Infect Control Hosp Epidemiol. 41(8): 914-920
Sacco et al. 2022 Nature Communications 13: 4370
Merchante et al. 2023 JAC Antimicrob Resist. 5(2): dlad033

see also:
Antibiotics & Clostridioides difficile infection (CDI)
Clostridioides difficile infection (CDI) & Gut microbiota
Clostridioides difficile infection (CDI) & Risk factors
Diarrhea / Diarrhoea (antibiotic-induced)

References (Sources)

A unique class of Zn2+-binding serine-based PBPs underlies cephalosporin resistance and sporogenesis of Clostridioides difficile
Sacco et al. 2022 Nature Communications 13: 4370
Prescriber perceptions of fluoroquinolones, extended-spectrum cephalosporins, and Clostridioides difficile infection
Szymczak et al. 2020 Infect Control Hosp Epidemiol. 41(8): 914-920
Role of previous systemic antibiotic therapy on the probability of recurrence after an initial episode of Clostridioides difficile infection treated with vancomycin
Merchante et al. 2023 JAC Antimicrob Resist. 5(2): dlad033
Third generation cephalosporins as a risk factor for Clostridium difﬁcile-associated disease: a four-year survey in a general hospital
de Lalla et al. 1989 J Antimicrob Chemother 23: 623-631

AI Chat

11/5/2026

Chat with our artificial intelligence: